Publicaciones

2023

Caracterización clínica y terapéutica de la cardiopatía isquémicaen España. Importancia de los programas de rehabilitación cardiaca.

Cordero A., Campuzano Ruiz R., Cequier Fillat Á., López De Sá Areses E., González-Juanatey J.R., en representacion de los investigadores del estudio RECARIS

Medicina Clínica Práctica. Volume 5, Issue 3, July–September 2022

Cardiovascular Area

Characterization and Clinical Association of Autoantibodies Against Perilipin 1 in Patients With Acquired Generalized Lipodystrophy.

Corvillo F, Abel BS, López-Lera A, Ceccarini G, Magno S, Santini F, Araújo-Vilar D, Brown RJ, Nozal P, López-Trascasa M

Diabetes. 2023 Jan 1;72(1):71-84.

Molecular Pathology of Rare Diseases

Clinical Spectrum of LMNA-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review.

Fernandez-Pombo A, Diaz-Lopez EJ, Castro AI, Sanchez-Iglesias S, Cobelo-Gomez S, Prado-Moraña T, Araujo-Vilar D.

Cells. 2023 Feb 24;12(5):725.

Molecular Pathology of Rare Diseases

Development and Characterization of Novel Selective, Non-Basic Dopamine D2 Receptor Antagonists for the Treatment of Schizophrenia.

Stępnicki P, Wośko S, Bartyzel A, Zięba A, Bartuzi D, Szałaj K, Wróbel TM, Fornal E, Carlsson J, Kędzierska E, Poleszak E, Castro M, Kaczor AA.

Molecules. 2023 May 20;28(10):4211.

Molecular Pharmacology of G protein-coupled receptors

Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents - Design, synthesis, structural studies and pharmacological profiling.

Stępnicki P, Targowska-Duda KM, Martínez AL, Zięba A, Wronikowska-Denysiuk O, Wróbel MZ, Bartyzel A, Trzpil A, Wróbel TM, Chodkowski A, Mirecka K, Karcz T, Szczepańska K, Loza MI, Budzyńska B, Turło J, Handzlik J, Fornal E, Poleszak E, Castro M, Kaczor AA.

Eur J Med Chem. 2023 Apr 5;252:115285.

Molecular Pharmacology of G protein-coupled receptors